The presence of foetal ganglioside antigens 3'-IsoLM1 and 3'6'-IsoLD1 in both glioma tissue and surrounding areas from human brain

Acta Neurochirurgica

Volumn 139, Issue 2, 1997, Pages 141-145

  Von Holst, H ^a   Nygren, C ^a   Bostrom K ^b   Collins, V P ^c   Fredman, P ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain tumours; Gangliosides; Glycoproteins; Glycosphingolipids; Tumour antigens

Indexed keywords

ANTIGEN; GANGLIOSIDE; GLYCOPHOSPHOLIPID;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR CELL;

EID: 0031059031     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02747194     Document Type: Article

References (16)

1. Berra B, Gaini SM, Riboni L (1985) Correlation between ganglioside distribution and histological grading of human astrocytomas. Int J Cancer 36: 363-366
2. Campanella L (1992) Membrane lipids modifications in human gliomas of different degree of malignancy. J Neurosurg Sci 36(1): 11-25
3. Fredman P, von Holst H, Collins VP, Ammar A, Dellheden B, Wahren B, Granholm L, Svennerholm L (1986) Potential ganglioside antigens associated with human gliomas. Neurol Res 8: 123-126
4. Fredman P, von Holst H, Collins VP, Granholm L, Svennerholm L (1988) Sialyllatotetraosylceramide, a ganglioside marker for human malignant gliomas. J Neurochem 50: 912-919
5. Fredman P, von Holst H, Collins VP, Dellheden B, Svennerholm L (1993) Expression of gangliosides GD3 and 3′-isoLM1 in autopsy brains from patients with malignant tumours. J Neurochem 60: 99-105
6. Hakomori SI (1986) Tumour associated glycolipid antigens, their metabolism and organisation. Chem Phys Lipids 42: 209-233
7. Hakomori SI (1989) Aberrant glycosylation in tumours and tumour-associated carbohydrate antigens. Adv Cancer Res 52: 257-331
8. Hakomori SI (1990) Bifunctional role of glycolipids. J Biol Chem 265: 18713-18716
9. von Holst H, Ericson K, Bergström M, Norén G (1990) Stereotactic positron emission tomography imaging for brain tumours. In: Lunsford LD (ed) Modern stereotactic surgery. Martinus Nijhoff, Boston, pp 195-205
10. Jenneman R, Mennel HD, Baver BL, Wiegandt H (1994) Glycosphingolipid component profiles of human gliomas correlate with histological tumor types analysis of interindividual and tumour region distribution. Acta Neurochir (Wien) 126: 170-178
11. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. Springer, Berlin Heidelberg New York Tokyo
12. 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol Diagn 6: 673-681
13. Månsson J-E, Fredman P, Bigner D, Molin K, Rosengren B, Friedman H-S, Svennerholm L (1986) Characterisation of new gangliosides of the lactotetraose series in murine xenografts of human glioma cell line. FEBS Lett 201: 109-113
14. Svennerholm L, Boström K, Fredman P, Månsson J-E, Rosengren B, Rynmark B-M (1989) Human brain gangliosides developmental change from early foetal stage to advanced age. Biochim Biophys Acta 1005: 109-117
15. Svennerholm L (1957) Quantitative estimation of sialic acids II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24: 604-611
16. Wikstrand CJ, Longee DC, McLendon RE, Fuller GN, Friedman HS, Fredman P, Svennerholm L, Bigner D (1993) Lactotetraose series ganglioside 3′6′-isoLD1 in tumours of central nervous and other systems in vitro and in vivo. Cancer Res 33: 1-7